Resultats de la cerca - Fujiwara, Tamio

Unidirectional Growth and Branch Formation of a Morphological Mutant, Agrobacterium tumefaciens per Fujiwara, Tamio, Fukui, Sakuzo

Obtenir text complet Obtenir text complet

Isolation of Morphological Mutants of Agrobacterium tumefaciens per Fujiwara, Tamio, Fukui, Sakuzo

Obtenir text complet Obtenir text complet

Barrier to Resistance of Dolutegravir in Two-Drug Combinations per Yoshinaga, Tomokazu, Miki, Shigeru, Kawauchi-Miki, Shinobu, Seki, Takahiro, Fujiwara, Tamio

Obtenir text complet Obtenir text complet Obtenir text complet

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers per Min, Sherene, Song, Ivy, Borland, Julie, Chen, Shuguang, Lou, Yu, Fujiwara, Tamio, Piscitelli, Stephen C.

Obtenir text complet Obtenir text complet Obtenir text complet

The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults per Underwood, Mark R., Johns, Brian A., Sato, Akihiko, Martin, Jeffrey N., Deeks, Steven G., Fujiwara, Tamio

Obtenir text complet Obtenir text complet Obtenir text complet

Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir per Quashie, Peter K., Mesplède, Thibault, Han, Ying-Shan, Oliveira, Maureen, Singhroy, Diane N., Fujiwara, Tamio, Underwood, Mark R., Wainberg, Mark A.

Obtenir text complet Obtenir text complet Obtenir text complet

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design per Goldgur, Yehuda, Craigie, Robert, Cohen, Gerson H., Fujiwara, Tamio, Yoshinaga, Tomokazu, Fujishita, Toshio, Sugimoto, Hirohiko, Endo, Takeshi, Murai, Hitoshi, Davies, David R.

Obtenir text complet Obtenir text complet

S-1153 Inhibits Replication of Known Drug-Resistant Strains of Human Immunodeficiency Virus Type 1 per Fujiwara, Tamio, Sato, Akihiko, El-Farrash, Mohamed, Miki, Shigeru, Abe, Kenji, Isaka, Yoshitaka, Kodama, Makoto, Wu, Yaming, Chen, Lan Bo, Harada, Hiroshi, Sugimoto, Hirohiko, Hatanaka, Masakazu, Hinuma, Yorio

Obtenir text complet Obtenir text complet

Effects of Raltegravir or Elvitegravir Resistance Signature Mutations on the Barrier to Dolutegravir Resistance In Vitro per Seki, Takahiro, Suyama-Kagitani, Akemi, Kawauchi-Miki, Shinobu, Miki, Shigeru, Wakasa-Morimoto, Chiaki, Akihisa, Erika, Nakahara, Koichiro, Kobayashi, Masanori, Underwood, Mark R., Sato, Akihiko, Fujiwara, Tamio, Yoshinaga, Tomokazu

Obtenir text complet Obtenir text complet Obtenir text complet

Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection per Yoshinaga, Tomokazu, Kobayashi, Masanori, Seki, Takahiro, Miki, Shigeru, Wakasa-Morimoto, Chiaki, Suyama-Kagitani, Akemi, Kawauchi-Miki, Shinobu, Taishi, Teruhiko, Kawasuji, Takashi, Johns, Brian A., Underwood, Mark R., Garvey, Edward P., Sato, Akihiko, Fujiwara, Tamio

Obtenir text complet Obtenir text complet Obtenir text complet

In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor per Kobayashi, Masanori, Yoshinaga, Tomokazu, Seki, Takahiro, Wakasa-Morimoto, Chiaki, Brown, Kevin W., Ferris, Robert, Foster, Scott A., Hazen, Richard J., Miki, Shigeru, Suyama-Kagitani, Akemi, Kawauchi-Miki, Shinobu, Taishi, Teruhiko, Kawasuji, Takashi, Johns, Brian A., Underwood, Mark R., Garvey, Edward P., Sato, Akihiko, Fujiwara, Tamio

Obtenir text complet Obtenir text complet Obtenir text complet

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral per Garvey, Edward P., Johns, Brian A., Gartland, Margaret J., Foster, Scott A., Miller, Wayne H., Ferris, Robert G., Hazen, Richard J., Underwood, Mark R., Boros, Eric E., Thompson, James B., Weatherhead, Jason G., Koble, Cecilia S., Allen, Scott H., Schaller, Lee T., Sherrill, Ronald G., Yoshinaga, Tomokazu, Kobayashi, Masanori, Wakasa-Morimoto, Chiaki, Miki, Shigeru, Nakahara, Koichiro, Noshi, Takeshi, Sato, Akihiko, Fujiwara, Tamio

Obtenir text complet Obtenir text complet Obtenir text complet

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral per Garvey, Edward P., Johns, Brian A., Gartland, Margaret J., Foster, Scott A., Miller, Wayne H., Ferris, Robert G., Hazen, Richard J., Underwood, Mark R., Boros, Eric E., Thompson, James B., Weatherhead, Jason G., Koble, Cecilia S., Allen, Scott H., Schaller, Lee T., Sherrill, Ronald G., Yoshinaga, Tomokazu, Kobayashi, Masanori, Wakasa-Morimoto, Chiaki, Miki, Shigeru, Nakahara, Koichiro, Noshi, Takeshi, Sato, Akihiko, Fujiwara, Tamio

Obtenir text complet Obtenir text complet

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study per Eron, Joseph J., Clotet, Bonaventura, Durant, Jacques, Katlama, Christine, Kumar, Princy, Lazzarin, Adriano, Poizot-Martin, Isabelle, Richmond, Gary, Soriano, Vincent, Ait-Khaled, Mounir, Fujiwara, Tamio, Huang, Jenny, Min, Sherene, Vavro, Cindy, Yeo, Jane, Walmsley, Sharon L., Cox, Joseph, Reynes, Jacques, Morlat, Philippe, Vittecoq, Daniel, Livrozet, Jean-Michel, Fernández, Pompeyo Viciana, Gatell, Jose M., DeJesus, Edwin, DeVente, Jerome, Lalezari, Jacob P., McCurdy, Lewis H., Sloan, Louis A., Young, Benjamin, LaMarca, Anthony, Hawkins, Trevor

Obtenir text complet Obtenir text complet Obtenir text complet